Table 2 Time-specific distribution of urinary BP-3 concentrations (ng/mL) during the perinatal period for 217 women in the EARTH Study
Na | Detection % | Geometric mean (95% CI) | Percentile | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Min | 25th | 50th | 75th | 90th | 95th | Max | ||||
Urine samples collected during preconception (mean preconception BP-3 exposure for each participant) | ||||||||||
BP-3 | 178 | 99.6% | 131.6 (102.5, 168.9) | <LOD | 50.4 | 118.3 | 431.3 | 1318.3 | 2469.3 | 9000.0 |
SG-adjusted BP-3 | 166.6 (130.1, 213.4) | <LOD | 58.7 | 153.6 | 494.5 | 1710.3 | 2370.2 | 8313.8 | ||
Urine samples collected during the first trimester (one sample per participant) | ||||||||||
BP-3 | 194 | 99.5% | 106.4 (81.7, 138.6) | <LOD | 29.8 | 78.5 | 364.7 | 1304.2 | 3397.7 | 9115.3 |
SG-adjusted BP-3 | 142.4 (109.5, 185.2) | <LOD | 39.0 | 124.6 | 500.3 | 1710.2 | 3818.3 | 7888.0 | ||
Urine samples collected during the second trimester (one sample per participant) | ||||||||||
BP-3 | 170 | 98.8% | 132.4 (95.8, 182.9) | <LOD | 33.0 | 130.9 | 667.0 | 1990.0 | 4577.2 | 21,728.9 |
SG-adjusted BP-3 | 189.1 (139.4, 256.5) | <LOD | 40.1 | 169.1 | 811.8 | 2960.5 | 5358.2 | 17,383.1 | ||